Bitcoin reaches $73,300 six-week high as ETFs purchase $240M worth. Analysts identify $78K-$80K resistance with 26% odds of reaching $80K in April.
Author: Trader Edge
Read More
Replimune (REPL) shares dropped 19% after FDA rejected RP1 melanoma therapy for the second time, citing trial design issues. Stock halted twice.
Replimune (REPL) stock plunged 19% after FDA rejected RP1 melanoma drug for second time, citing inadequate clinical trial controls and design issues.
Replimune (REPL) stock plunged 19% after FDA rejected RP1 melanoma therapy for the second time, citing trial design flaws. Shares hit lowest level since Oct.
Michael Burry reveals purchases of Alibaba, JD.com, and GameStop shares while increasing put options on Nvidia and Palantir in his latest portfolio update.
Michael Burry discloses new stakes in Alibaba and JD.com while expanding bearish bets against Nvidia and Palantir through long-dated put options.
FICO stock dropped 13% Friday amid Senate pricing investigation and Barclays downgrade, falling to its lowest point since November 2023.
Fair Isaac (FICO) stock crashed 13% Friday as Senate investigation into pricing practices and Barclays target cut drove shares to lowest close since 2023.
PayPal (PYPL) integrates Payment Links into Canva’s platform, reaching 265M users. Stock edges higher on news but faces mixed analyst sentiment.
AMD stock surged 6% after TSMC posted 35% Q1 revenue growth to $35.6B, signaling robust AI chip demand ahead of AMD’s May 5 earnings report.
Super Micro Computer (SMCI) stock gained 6% on April 10 with call options activity surging and 87% implied volatility hinting at significant moves ahead.
CrowdStrike (CRWD) stock dropped 5% on AI disruption concerns before rallying on Anthropic’s Project Glass Wing partnership. Analysis of the volatility.
Nio stock climbed ~8% on ES9 SUV debut with proprietary chips, first quarterly GAAP profit, and 98% YoY delivery growth in Q1 2026.
Citi initiates IBM (IBM) with Buy rating and $285 target, citing AI tailwinds, mainframe cycle strength, and strategic acquisition synergies.
Nebius (NBIS) reached record highs this week, climbing 21% on AI21 Labs acquisition rumors and new analyst coverage. Stock up 549% year-over-year.